Noteworthy Wednesday Option Activity: MRNA, APGE, EU

Apogee Therapeutics Inc (APGE) and Encore Energy Corp (EU) recently experienced significant options trading activity, with APGE's options volume reaching 52.4% of its average daily share volume, notably in April 2026 $50 strike call options. Similarly, EU's options volume comprised 50.2% of its average daily share volume, driven by substantial trading in November 2025 $4 strike call options, indicating heightened investor interest or strategic positioning in these names.

Analysis

Apogee Therapeutics Inc (Symbol: APGE) saw options trading volume of 2,851 contracts, representing approximately 285,100 underlying shares or approximately 52.4% of APGE's average daily trading volume over the past month, of 543,655 shares. Especially high volume was seen for the $50 strike call option expiring April 17, 2026, with 2,283 contracts trading so far today, representing approximately 228,300 underlying shares of APGE. Below is a chart showing APGE's trailing twelve month trading history, with the $50 strike highlighted in orange: And Encore Energy Corp (Symbol: EU) saw options trading volume of 23,336 contracts, representing approximately 2.3 million underlying shares or approximately 50.2% of EU's average daily trading volume over the past month, of 4.6 million shares. Especially high volume was seen for the $4 strike call option expiring November 21, 2025, with 10,437 contracts trading so far today, representing approximately 1.0 million underlying shares of EU. Below is a chart showing EU's trailing twelve month trading history, with the $4 strike highlighted in orange: For the various different available expirations for MRNA options, APGE options, or EU options, visit StockOptionsChannel.com. Today's Most Active Call & Put Options of the S&P 500 » Also see: Institutional Holders of ONCS Funds Holding AIMD HYLB Options Chain The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Apogee Therapeutics Inc. (APGE) recently experienced notable options trading volume, with 2,851 contracts traded, equating to approximately 285,100 underlying shares. This volume represents a significant 52.4% of APGE's average daily trading volume of 543,655 shares over the past month. A substantial portion of this activity was concentrated in the $50 strike call option expiring April 17, 2026, which saw 2,283 contracts trade, indicating specific long-term bullish interest or strategic positioning at this price target. Similarly, Encore Energy Corp. (EU) also exhibited elevated options activity, recording 23,336 contracts traded, representing about 2.3 million underlying shares. This volume constituted 50.2% of EU's average daily trading volume of 4.6 million shares over the last month. The $4 strike call option expiring November 21, 2025, was particularly active, with 10,437 contracts trading, suggesting a similar pattern of targeted bullish sentiment or hedging activity for EU. The high options trading volume relative to the underlying stocks' average daily share volume for both APGE and EU points to increased investor interest or significant strategic maneuvers by market participants. The concentration in specific, out-of-the-money call options with relatively distant expirations suggests expectations of future price appreciation or a strategic use of derivatives for leverage or hedging. This activity aligns with the 'Derivatives & Volatility' and 'Market Technicals & Flows' themes identified, signaling an area for closer fundamental scrutiny. While the overall sentiment remains neutral, this pronounced options activity warrants attention as it can precede significant price movements or reflect informed positions. Such concentrated long-dated call buying often indicates confidence in a company's longer-term prospects or upcoming catalysts, which may not yet be reflected in the underlying share price. Investors should therefore consider the implications of this activity in their assessment of these two equities.

Key Decisions for Investors

• Investors should monitor APGE and EU for potential catalysts that could justify the significant long-dated call option interest, such as upcoming earnings, clinical trial results, or strategic announcements.
• Given the substantial options activity, particularly in specific call strikes, consider analyzing the open interest and implied volatility for these names to gauge market expectations for price movements and potential risk.